AstraZeneca announces insitro collaboration: stock pre-market at EUR 148.70
Published on 10/16/2026 at 08:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCollaboration and session timing
- AstraZeneca announced an insitro collaboration on October 15, 2026, focused on AI-supported cardiometabolic therapeutics.
- AstraZeneca stock trades pre-market at EUR 148.70 at 7:58 a.m. CEST at Lang & Schwarz on October 16, 2026.
- The next Xetra session is scheduled for 9:00 a.m. CEST on October 16, 2026.
AstraZeneca announced a strategic collaboration with insitro on October 15, 2026, to use advanced artificial intelligence systems to develop therapeutics for difficult-to-treat cardiometabolic diseases. The announcement appears in the company's latest press releases.
At 7:58 a.m. CEST on October 16, 2026, AstraZeneca stock was at EUR 148.70 pre-market at Lang & Schwarz. The bid was EUR 147.65 and the ask was EUR 149.75.
What matters today
The next Xetra session is scheduled for October 16, 2026, at 9:00 a.m. CEST. The round-number level EUR 150.00 is 0.87 percent above the Lang & Schwarz price. The quote was timestamped 7:58 a.m. CEST on October 16, 2026.
The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of AstraZeneca stock.
Market context: Market report FTSE 100.
